Table 2.
Patient Data | LDLT N=100 | CDLT N=424 | p |
---|---|---|---|
| |||
Pre-operative variables | |||
| |||
Patient age (years) | 52.7±12 | 56.7±9.5 | 0.002 |
Patient gender (male) | 53% | 32.5% | <0.001 |
Patient weight (kg) | 80 [66; 90] | 85 [72; 97] | 0.006 |
Patient race (Caucasian) | 94% | 94.60% | 0.94 |
(MELD) score | 13 [9; 15] | 19 [14; 22] | <0.001 |
Child score | 8 [7; 10] | 9 [7; 10] | 0.106 |
Pre-transplant serum creatinine (mg/dl) | 0.9 [0.8; 1.1] | 1 [0.8; 1.3] | <0.001 |
Pre-existing diabetes mellitus | 28% | 31.8% | 0.456 |
Pre-existing coronary artery disease | 6% | 5% | 0.67 |
| |||
Intraoperative variables | |||
| |||
Total operative time (h) | 7.8 [6.8; 87] | 7.2 [6; 8.3] | <0.001 |
Cold ischemic time (h) | 2 [1.6; 2.7] | 11 [8.8; 12.] | <0.001 |
Warm ischemic time (min) | 32 [29; 38] | 27 [23; 31] | <0.001 |
Veno-venous bypass use | 97% | 92% | 0.075 |
Methylene blue use | 65% | 80% | 0.002 |
Aprotinin use | 3.0% | 14.5% | 0.002 |
Post-reperfusion syndrome | 12% | 45.80% | <0.001 |
Crystalloid use (l) | 5 [3.7; 6.5] | 4.6 [3.5; 5.7] | 0.026 |
Colloid use (l) | 2.5 [2; 3.3] | 2.5 [1.5; 3.5] | 0.199 |
Red blood cells (units) | 4 [2; 7] | 6 [4; 10] | <0.001 |
Fresh frozen plasma (units) | 2 [0; 4] | 5 [2; 14] | <0.001 |
Platelets (units) | 1 [0; 1] | 1 [0; 2] | <0.001 |
Cryoprecipitate (units) | 0 [0; 0] | 0 [0; 1] | <0.001 |